Quan Anh Vu

Chief Operating Officer, FORUM MARKETS Inc.

Companies

Monopar TherapeuticsChief financial officer Mar 5, 2025 to now¹
OcugenChief financial officer Mar 10, 2023 to Mar 10, 2023²
FORUM MARKETS IncChief operating officer Nov 4, 2021 to Dec 16, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Monopar Therapeutics MNPR2,221 shares⁴$157.2K at $70.76Jun 30, 2026
Ocugen OCGN165,934 shares⁵$133.2K at $0.80Mar 10, 2023
FORUM MARKETS Inc FRMM20,500 shares⁶$68.1K at $3.32Dec 16, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 30, 2026Shares withheld for tax 507 shares at $92.59 of Monopar Therapeutics⁴
Jun 30, 2026Exercised options 1,228 shares of Monopar Therapeutics⁴
Dec 26, 2025Bought 1,500 shares at $69.95 of Monopar Therapeutics⁷
Dec 16, 2021Bought 8,000 shares at $3.98 of FORUM MARKETS Inc⁶
Dec 10, 2021Bought 4,500 shares at $3.90 of FORUM MARKETS Inc⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMonopar Therapeutics, Chief financial officer
2
SEC EDGAROcugen, Chief financial officer
3
SEC EDGARFORUM MARKETS Inc, Chief operating officer
4
SEC EDGARMonopar Therapeutics shares after the filing of Jun 30, 2026
5
SEC EDGAROcugen shares after the filing of Mar 10, 2023
6
SEC EDGARFORUM MARKETS Inc shares after the filing of Dec 16, 2021
7
SEC EDGARForm 4 filed Dec 29, 2025
8
SEC EDGARForm 4 filed Dec 10, 2021